Castle biosciences presents new data on the validity and accuracy of decisiondx-melanoma in patients with t1 cutaneous melanoma tumors at the 19th annual south beach symposium

Friendswood, texas--(business wire)---- $cstl #castlebiosciences--castle today announced virtual posters on its three skin cancer gene expression profile tests at the 19th annual south beach symposium.
CSTL Ratings Summary
CSTL Quant Ranking